| scholarly article | Q13442814 |
| P50 | author | Ian Chopra | Q105819967 |
| Alexander John O'Neill | Q117255457 | ||
| Keith Miller | Q40739161 | ||
| P2860 | cites work | Alteration of ribosomal protein L6 in mutants of Escherichia coli resistant to gentamicin | Q40860877 |
| Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window | Q43896553 | ||
| Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. | Q44012036 | ||
| Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid | Q44235733 | ||
| Site-directed mutagenesis of mouse dihydrofolate reductase. Mutants with increased resistance to methotrexate and trimethoprim. | Q54376787 | ||
| Anaerobic bacteria in the urinary tract | Q69155752 | ||
| Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim | Q69880862 | ||
| Pharmacokinetics of cefotaxime in healthy volunteers and patients | Q71809640 | ||
| Tetracycline antibiotics should be avoided in patients with renal disease | Q72028648 | ||
| Decreased membrane permeability in a polymyxin B-resistant Escherichia coli mutant exhibiting multiple resistance to beta-lactams as well as aminoglycosides | Q74505333 | ||
| Detection of antimicrobial activity in urine for epidemiologic studies of antibiotic use | Q78008761 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae | Q33694946 | ||
| Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli | Q33698034 | ||
| Mutation frequencies and antibiotic resistance | Q33945503 | ||
| Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump | Q33978398 | ||
| Low-level antibacterial resistance: a gateway to clinical resistance | Q34341270 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection | Q34756632 | ||
| Evolution and spread of antibiotic resistance | Q34792403 | ||
| Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. | Q35138349 | ||
| Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae | Q35138848 | ||
| The role of mutators in the emergence of antibiotic-resistant bacteria | Q35177659 | ||
| Role of porin proteins OmpF and OmpC in the permeation of beta-lactams | Q35761633 | ||
| Two bacteriophages which utilize a new Escherichia coli major outer membrane protein as part of their receptor | Q36469612 | ||
| Anaerobic infections of the urinary tract: are they being missed? | Q37227372 | ||
| Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae | Q39476866 | ||
| Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes | Q39476891 | ||
| High frequency of mutator strains among human uropathogenic Escherichia coli isolates. | Q39694657 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| antibiotic resistance | Q380775 | ||
| P304 | page(s) | 23-29 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections | |
| P478 | volume | 48 |
| Q46813853 | Antibiotic resistance and hypermutability of Escherichia coli O157 from feedlot cattle treated with growth-promoting agents. |
| Q41112867 | Antimicrobial susceptibility patterns of clinical Escherichia coli isolates from dogs and cats in the United States: January 2008 through January 2013. |
| Q39240801 | Chronic urinary tract infections in patients with spinal cord lesions - biofilm infection with need for long-term antibiotic treatment |
| Q36178618 | Diversify or die: generation of diversity in response to stress. |
| Q33956548 | False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins |
| Q39656697 | Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections |
| Q46616248 | High prevalence of multiple-antibiotic-resistant (MAR) Escherichia coli in river bed sediments of the Apies River, South Africa. |
| Q37922538 | Hypermutation and stress adaptation in bacteria |
| Q39609549 | Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum beta-lactamases |
| Q37007127 | Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates |
| Q33709710 | Proteomic analysis of Salmonella enterica serovar Enteritidis following propionate adaptation |
| Q37033480 | The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients |
| Q35550294 | What should be considered if you decide to build your own mathematical model for predicting the development of bacterial resistance? Recommendations based on a systematic review of the literature |
Search more.